Hormonal Contraceptives Market Thumbnail Image

2022

Hormonal Contraceptives Market

Hormonal Contraceptives Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, Hormones, Age Group End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

LS : Pharmaceuticals

Select an option
Author's: Vikita Thakur | Roshan Deshmukh
Publish Date:

Get Sample to Email

Hormonal Contraceptives Market Overview 2030:

The global hormonal contraceptives market size was valued at $ 15,026.23 million in 2020, and is projected to reach $ 20,672.64 million by 2030, registering a CAGR of 3.3% from 2021 to 2030. Hormonal contraceptives are birth control methods, which act on the endocrine system. These methods include use of hormones that are produced normally by women, such as estrogen and progesterone, to prevent ovulation and in turn pregnancy. However, they do not provide protection against HIV or other sexually transmitted infections. There are two types of hormonal contraceptives available in the market, namely, progestin-only contraceptive and combination hormonal contraceptive. Hormonal contraception acts on the endocrine system to prevent unwanted pregnancy. 

Synthetic forms of naturally occurring hormones such as progestin and estrogen are used to prevent ovulation and avoid fertilization. These forms of birth control methods also change the environment of the uterus, making it unfavorable for fertilization. They are available in a variety of forms such as patches, pills, injections, and rings, which are safe and reliable forms of hormonal contraceptives to prevent pregnancy.

Hormonal-Contraceptives-Market

Request Sample Page

Hormonal contraceptive is expected to exhibit significant market growth during the forecast period, owing to increase in focus toward family planning and need for preventing unintended pregnancy. Key factors driving growth of the market growth are attributed to health issues associated with teenage pregnancies, increase in awareness about modern contraception methods, and rise in use of oral pills as a key method to prevent unplanned pregnancy, which propel the market growth. However, availability of alternate contraceptive methods, health risks associated with use of contraceptives, and lack of social acceptance are expected to restrain the hormonal contraceptives market growth. 

The global hormonal contraceptives market is segmented on the basis of product, hormone, age group, end user, and region. By product, the market is divided into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal rings, and transdermal patches. On the basis of hormones, it is divided into progestin-only contraceptive and combined hormonal contraceptive. On the basis of age group, it is divided into 15–24 years, 25–34 years, 35–44 years, and above 44 years. By end user, it is divided into hospitals, household, and clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Impact Of Covid-19 On Hormonal Contraceptives Market (Pre And Post Analysis)

Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans. 

After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On March 11, 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, only a few vaccines that received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns. 

The overall impact of COVID-19 remains slightly negative on the hormonal contraceptives market, owing to decline in family planning and need for preventing unintended pregnancy in pandemic and these hormonal contraceptives are mainly used in family planning. For instance, according to the UNFPAs in 2020 family planning activities are largely disrupted or declined by 3.6% as compared to previous year in COVD-19, Thus, aforementioned factors led to decline hormonal contraception products.

By Product Segment Review

By product type, the hormonal contraceptives market is divided into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal rings, and transdermal patches. The oral contraceptive pill segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, owing due to these pills are easily available and have high success rate of up to 99% to prevent pregnancy. On the other side, the demand for vaginal rings projected to exhibit the fastest market growth during the forecast period, owing to ease of usage and fewer side effects caused by it.

Hormonal Contraceptives Market
By Product
Your browser does not support the canvas element.

Oral Contraceptive Pills segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

By Hormone Segment Review

By hormone, the hormonal contraceptives market is classified as progestin-only contraceptive and combined hormonal contraceptive. The combined hormonal contraceptive segment presently dominates the market, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate, owing to wide availability of combined hormonal contraceptive along with better efficiency to prevent pregnancy.

Hormonal Contraceptives Market
By Hormone
Your browser does not support the canvas element.

Combined Hormonal Contraceptive segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

By Age Group Segment Review

By age group, the hormonal contraceptives market is classified as 15–24 years, 25–34 years, 35–44 years, and above 44 years. The 15–24 years segment presently dominates the market, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate, owing to increase in awareness regarding hormonal contraceptives, rise in adoption emergency contraceptive pills among adults, and rise in concern about adolescent sexual activity, specifically owing to premarital and unplanned pregnancy often leads to premature discontinuation of schooling or abortion.

Hormonal Contraceptives Market
By Age Group
Your browser does not support the canvas element.

15 To 24 Years segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

By End User Segment Review

By end user, the hormonal contraceptives market is classified as hospitals, household, and clinics. The household segment presently dominates the market, and is expected to remain dominant during the forecast period, owing to wide consumption of oral pills to avoid unplanned pregnancy. In addition, increase in use of contraceptives at home has improved health-related outcomes such as maternal and infant mortality.

Hormonal Contraceptives Market
By End Users
Your browser does not support the canvas element.

Household segements holds a dominant position in 2020 and continue to maintain lead in the forecast year

Region segment review

By region, the hormonal contraceptives market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period, owing to the high adoption of hormonal contraceptives, well-established healthcare infrastructure, and presence of key market players in the region. The North America hormonal contraceptives market is expected to grow at significant rates. According to the Center for Disease Control and Prevention (CDC), from 2018 to 2020, 72.2 million U.S. woman aged between 19–49 was using contraceptives. In addition, government initiatives are increasing awareness regarding birth control and growing affordability, which fuels the market growth.

Hormonal Contraceptives Market
By Region
2030
North America 
Europe
Asia-Pacific
LAMEA

North America region holds the dominant position in 2020 and would exhibit the highest CAGR of 8.0 % during 2021-2030

This report provides comprehensive competitive analysis and profiles of prominent market players such as key players operating in the Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis of the current market trends for hormonal contraceptives market from 2020 to 2030 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global hormonal contraceptives market is comprehensively analyzed with respect to product, hormone type, age group, end user, and region.
  • In-depth analysis based on region assists in understanding the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the hormonal contraceptives market.

Hormonal Contraceptives Market Report Highlights

Aspects Details
icon_5
By Product
  • Oral Contraceptive Pills
  • Injectable Birth Control
  • Emergency Contraceptive Pills
  • Vaginal Rings
  • Transdermal Patches
icon_6
By Hormones
  • Progestin-only Contraceptive
  • Combined Hormonal Contraceptive
icon_7
By End User
  • Hospitals
  • Household
  • Clinics
icon_8
By End User
  • 15–24 Years
  • 25–34 Years
  • 35–44 Years
  • Above 44 Years
icon_9
By Region
  • North America   (U.S., Canada, Mexico)
  • Europe   (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific   (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA   (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
icon_10
By KEY PLAYERS
  • the Female Health Company
  • Teva Pharmaceutical Industries Limited
  • Bayer AG, Pfizer, Inc.
  • Mylan N.V.
  • Johnson & Johnson
  • Ansell LTD.
  • Mayer Laboratories
  • Merck & Co., Inc.,
  • Church & Dwight, Co., Inc.

Analyst Review

According to opinions of top-level CXOs, government initiatives to spread awareness toward benefits of family planning & birth control and prevention of unplanned pregnancy are expected to play a major role in growth of the hormonal contraceptive market. Advancements in hormonal contraceptive technologies & methods for development of products with enhanced efficiency & fewer side effects and increase in use of contraceptive drug & devices further boost the market growth. Moreover, hormonal contraceptives have piqued the interest of healthcare providers, owing to benefits offered by these drugs and devices along with higher efficiency to prevent unwanted pregnancy. However, lack of reimbursement policies and high cost of new contraceptive devices hamper the market growth. Currently, oral contraceptive or pill segment garner the highest revenue share in the hormonal contraceptives market, followed by vaginal rings.

Household users accounted for a significant share of the market, owing to use of user-friendly hormonal contraceptive methods such as pills, rings, and patches. In addition, contraceptive manufacturers have focused on marketing novel contraceptives for household users through various media such as television, internet, and others.

The use of hormonal contraceptive system is highest in North America, particularly in the U.S., owing to rise in awareness about benefits of using hormonal contraceptive and favorable regulatory scenario. Although the use of hormonal contraceptive in Asia-Pacific and LAMEA is low, adoption rate is expected to increase in the future, owing to presence of populace countries such as India and China, where there is higher need to control the growing population.

 

Author Name(s) : Vikita Thakur | Roshan Deshmukh
Frequently Asked Questions?

The total market value of Hormonal Contraceptives Market is 20,672.64 Million in 2030

The forecast period in the report is from 2021 to 2030

The market value of Hormonal Contraceptives in 2020 was $ 15,026.23 million in 2020

The base year for the report is 2020

Yes, Hormonal Contraceptives Market companies are profiled in the report

The top companies that hold the market share in Hormonal Contraceptives Market are Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.

No, there is no value chain analysis provided in the Hormonal Contraceptives Market report

the key factors that drive the market growth are are increase in focus towards family planning and need for preventing unintended pregnancy. The advancement in hormonal contraception with enhanced efficacy and fewer side effects are expected to further boost the market growth

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Hormonal Contraceptives Market

Global Opportunity Analysis and Industry Forecast, 2021-2030